An OHSU study focused on rural residents finds a promising method for eliminating hepatitis C, a common and potentially fatal disease that afflicts many drug users. Andrew Seaman, M.D., says, “We have life-saving medications to treat hepatitis C. This study shows that finding unique ways to improve access to treatment — beyond traditional health care settings — is crucial for supporting people who use drugs.”

In an Axios Portland story about a 65% increase in participation in an OHSU program to improve addiction medicine training among health care professionals and law enforcement officers statewide, Dan Hoover, M.D., says, “What I want to see happen is that there’s no wrong door that a patient with substance use disorder could come into.”

“What I want to see happen is that there’s no wrong door that a patient with substance use disorder could come into.”

“There seems to be a window of opportunity within two months,” Laurie King, senior study author and professor of neurology at Oregon Health & Science University, said in a news release.

In stories about the severity of this flu season, Dawn Nolt, M.D., notes that there has been a rapid rise in flu cases locally and nationally, and gives advice on how to stay healthy. Among other things, she says, “After you recover from flu, there are a lot of other respiratory germs out there, so really wash your hands meticulously.”

“There seems to be a window of opportunity within two months,” Laurie King, a professor of neurology at Oregon Health & Science University School of Medicine and the study’s senior author, said in a news release. “After that point, the brain compensates in a way that’s not good.”

The Washington Post covers new OHSU research that suggests people with continuing symptoms of concussion should seek physical therapy as soon as possible. Laurie King, Ph.D., says, “There seems to be a window of opportunity within two months. After that point, the brain compensates in a way that’s not good.”

In a Renal & Urology News story highlighting a novel polygenic risk score that may be useful for identifying men on active surveillance for prostate cancer, Mark Garzotto, M.D., says personalized approaches to active surveillance promise improvement in clinical outcomes while reducing health care expenditures; however, the risk score does not have a defined role in active surveillance.

A multi-institutional team of scientists developed a free, publicly accessible resource to aid in the classification of patient tumor samples. Kyle Ellrott, Ph.D., says: “A major element of this effort was working to ensure that these models could be deployed by other groups onto new datasets. All too often this type of work is difficult to replicate or apply to new samples.”

A multi-institutional team of scientists developed a free, publicly accessible resource to aid in the classification of patient tumor samples. Kyle Ellrott, Ph.D., says: “A major element of this effort was working to ensure that these models could be deployed by other groups onto new datasets. All too often this type of work is difficult to replicate or apply to new samples.”